The Care Pathway Delays of Cervical Cancer Patient in Morocco

Table 5

Results of multiple linear regression between cervical cancer delay and sociodemographic and clinical factors (n = 190).

Variables	Patient delay (β (95% CI) value)	Healthcare provider (β (95% CI) value)	Referral delay (β (95% CI) value)	Diagnosis delay (β (95% CI) value)
Age
25–34	1.64 (−2.4; 5.67) 0.423	−1.18 (−3.13; 0.761) 0.229	−0.7 2 (−3.45; 2.01) 0.601	2.57 (−0.643; 5.78) 0.113
35–44	2.1 (0.0748; 4.13) 0.042	−0.151 (−1.06; 0.76) 0.743	−0.714 (−1.51; 0.789) 0.077	3.14 (1.35; 4.93) 0.001
45–54 (ref)
55–64	0.542 (−1.26; 2.34) 0.553	0.233 (−0.42; 0.886) 0.48	0.335 (−0.35; 1.02) 0.334	−0.0891 (−1.21; 1.03) 0.872
>65	0.65 (−1.23; 2.53) 0.495	0.951 (0.121; 1.78) 0.025	−0.16 (−0.958; 0.638) 0.691	−0.386 (−1.64; 0.865) 0.534
Marital status
Divorced	—	−0.438 (−1.23; 0.357) 0.276	−0.582 (−1.47; 0.309) 0.198	—
Widow		−0.317 (−1.08; 0.45) 0.413	−0.238 (−0.939; 0.464) 0.502
Married (ref)
Study level
Primary school		0.181 (−0.979; 1.02) 0.971	0.507 (−0.401; 1.41) 0.270	—
Secondary school	—	0.229 (−0.571; 1.03) 0.571	−0.238 (−0.939; 0.464) 0.502
None (ref)
Age of first sexual activity	0.0381 (−0.175; 0.251) 0.724	0.896 (0.178; 1.61) 0.015	−0.032 (−0.135; 0.0712) 0.539	−0.238 (−0.423;−0.0531) 0.013
Hospital referrer
Self-reference	−0.531 (−3.1; 2.04) 0.683	0.428 (−0.681; 1.54) 0.445	0.156 (−0.9090; 1.22) 0.771	0.0987 (−1.42; 1.62) 0.895
General practitioner	1.51 (−1.17; 4.2) 0.266	−0.469 (−2.04; 1.1) 0.553	0.162 (−1.01; 1.33) 0.783	−0.476 (−1.81; 0.858) 0.473
Specialist physician	−0.923 (−2.4; 0.554) 0.219	0.875 (0.238; 1.51) 0.008	−0.342 (−1.02; 0.335) 0.318	−0.0239 (−1.04; 0.994) 0.962
Private physician (ref)
Stage
I	−1.2 (−2.99; 059) 0.187	1.98 (−0.445; 0.84) 0.542	0.457 (−0.21; 1.12) 0.177	0.11 (−0.951; 1.17) 0.834
II (ref)
III	−0.862 (−0.273; 1.01) 0.364	−0.264 (−0.973; 0.446) 0.462	−0.197 (−0.96; 0566) 0.609	−0.917 (−2.67; 0.837) 0.295
IV	−1.56 (−4.04; 0.923) 0.216	0.54 (−0.418; 1.5) 0.265	−0.52 (−1.44; 0.397) 0.263	−0.698 (−1.87; 0.478) 0.236
Tumor grade
Well-differentiated (ref)
Undifferentiated	—	0.848 (0.749; 1.62) 0.032	0.699 (−0.118; 1.52) 0.093	0.163 (−0.776; 1.1) 0.727
Mildly differentiated	—	0.683 (−0.517; 0.654) 0.817	0.21 (−0.374; 0.794) 0.477	−0.702 (−1.65; 0.241) 0.139
Diagnosis year
<2012 (ref)
2012	3.05 (0.16; 5.94) 0.039	−3 (−4.02;−1.97) 0.001	0.754 (−0.323; 1.83) 0.167	0.169 (−1.54; 1.88) 0.842
2013	0.648 (−1.72; 3.01) 0.588	−3.5 (−4.38;−2.62) 0.001	−0.321 (−1.27; 0.632) 0.505	−0.106 (−1.89; 1.68) 0.905
2014	3.04 (0.684; 5.39) 0.012	−3.18 (−4.19;−2.16) 0.001	0.557 (−0.527; 1.64) 0.309	0.953 (−0.705; 2.61) 0.250
2015	2.06 (−0.38; 4.51) 0.097	−2.98 (−3.89;−2.06) 0.001	−0.29 (−1.28; 0.702) 0.562	−0.457 (−2.2; 1.29) 0.597
2016	2.8 (0.568; 5.03) 0.014	−3.42 (−4.56;−2.27) 0.001	0.48 1 (−0.586; 1.55) 0.372	1.11 (−0.771; 2.99) 0.238
2017	2.01 (−0.395; 4.41) 0.101	−2.87 (−3.9;−1.85) 0.001	0.488 (−0.584; 1.56) 0.368	—
Investigation before the oncology center
Yes	—	1.02 (0.136; 0.191) 0.024	−1.27 (−1.95; −0.583) 0.001	001–0.569 (−1.45; 0.309) 0.196
No (ref)
Variables	Total diagnosis delay (β (95% CI) P value)	Treatment delay (β (95% CI) P value)	Health system interval (β (95% CI) P value)
Age
25–34	−0.406 (−2.22; 1.41) 0.658	4.64 (−70.6; 79.9) 0.903	0.0465 (−1.03; 1.13) 0.932
35–44	0.409 (−0.41; 1.23) 0.324	11.1 (−15.3; 37.5) 0.405	0.0612 (−0.355; 0.477) 0.770
45–54 (ref)
55–64	0.196 (−0.381; 0.772) 0.502	2.32 (−23.1; 27.7) 0.856	0.242 (−0.121; 0.605) 0.188
>65	0.237 (−0.424; 0.898) 0.478	−25.3 (−53.4; 2.81) 0.077	−0.493 (−0.899; −0.874) 0.018
Marital status
Divorced	−0.322 (−1.08; 0.436) 0.401	−12.4 (−45.8; 20.9) 0.460	−0.488 (−0.952; −0.025) 0.039
Widow	0.131 (−0.471; 0.734) 0.667	18.7 (−7.84; 45.2) 0.165	0.385 (0.0176; 0.753) 0.040
Married (ref)
Study level
Primary school	−0.0135 (−0.689; 0.662) 0.969	0.207 (−32.3; 32.7) 0.990	0.165 (−0.26; 0.59) 0.442
Secondary school	0.139 (−0.621; 0.898) 0.718	−17.5 (−52.6; 17.5) 0.322	−0.377 (−0.838; 0.0845) 0.108
None (ref)
Age of first sexual activity	—	−3.55 (−6.78; −0.323) 0.031	0.038 (−0.00491; 0.0808) 0.082
Hospital referrer
Self-reference		—	−0.163 (−0.706; 0.381) 0.0.554
General practitioner	—		−0.829 (−1.43;−0.225) 0.008
Specialist physician			−0.049 (−0.394; 0.296) 0.778
Private physician (ref)
Stage
I	−0.3 (−0.864; 0.264) 0.294	−20.7 (−45.2; 3.8) 0.097	−0.233 (−0.6; 0.133) 0.209
II (ref)
III	−0.431 (−1.02; 0.157) 0.149	−71 (−33.8; 19.6) 0.599	−0.167 (−0.55; 0.216) 0.388
IV	−0.619 (−1.4; 0.158) 0.117	−0.585 (−36.4; 35.2) 0.974	−0.0316 (−0.528; 0.465) 0.90
Tumor grade
Well-differentiated (ref)
Undifferentiated	0369 (−0.286; 1.02) 0.266	29.8 (1.08; 58.5) 0.042	0.373 (−0.0449; 0.79) 0.080
Mildly differentiated	−0.333 (−0.826; 0.161) 0.184	−6.53 (−29; 16) 0.565	−0.0447 (−0.363; 0.274) 0.781
Diagnosis year
<2012 (ref)
2012	−1.2 (−2.1;−0.307) 0.009	−26.5 (−70.9; 17.8) 0.238	0.026 (−0.599; 0.651) 0.943
2013	−0.956 (−1.79; −0.118) 0.026	−23 (−58.9; 12.9) 0.206	−0.0659 (−0.614; 0.482) 0.812
2014	−0.66 (−1.57; 0.248) 0.152	−21.7 (−58.1; 14.6) 0.238	0.261 (−0.349; 0.871) 0.397
2015	−0.562 (−1.37; 0.245) 0.170	−43.9 (−76.9; −10.9) 0.010	−0.00165 (−0.555; 0.552) 0.995
2016	−0.51 (−1.39; 0.365) 0.250	−28.3 (−67.2; 10.6) 0. 151	0.163 (−0.43; 0.757) 0.585
2017	−0.209 (−1.06; 0.64) 0.626	−30.8 (−68.4; 6.84) 0.108	−0.0885 (−0.663; 0.486) 0.760
Investigation before the oncology center
Yes	−0.359 (−0.922; 0.203) 0.208	−5.54 (−30.3; 19.3) 0.658	—
No (ref)

Significant at value < 0.05/model included variables that were significant on univariate analyses at the (0.05 level).